| Hazard Information | Back Directory | [Uses]
PSMA-Val-Cit-PAB-MMAE is a novel small-molecule PSMA-targeted conjugate based on the monomethyl auristatin E for the chemotherapy of prostate cancer. | [IC 50]
Auristatin | [References]
[1] Machulkin AE, et al. Synthesis, Characterization, and Preclinical Evaluation of a Small-Molecule Prostate-Specific Membrane Antigen-Targeted Monomethyl Auristatin E Conjugate. J Med Chem. 2021 Nov 19. DOI:10.1021/acs.jmedchem.1c01157 |
|
| Company Name: |
YantaiBio
|
| Tel: |
13758194781 |
| Website: |
|
|